Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Cash from Financing Activities (2020 - 2025)

Bio Essence (BIOE) has 6 years of Cash from Financing Activities data on record, last reported at -$158232.0 in Q3 2025.

  • For Q3 2025, Cash from Financing Activities rose 51.68% year-over-year to -$158232.0; the TTM value through Sep 2025 reached -$762167.0, down 684.79%, while the annual FY2024 figure was -$622494.0, 156.03% down from the prior year.
  • Cash from Financing Activities reached -$158232.0 in Q3 2025 per BIOE's latest filing, up from -$167797.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $828847.0 in Q2 2021 and bottomed at -$460836.0 in Q4 2024.
  • Average Cash from Financing Activities over 5 years is $127814.8, with a median of $190641.0 recorded in 2022.
  • Peak YoY movement for Cash from Financing Activities: surged 226.5% in 2021, then tumbled 1009.04% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $206002.0 in 2021, then increased by 0.77% to $207586.0 in 2022, then surged by 40.66% to $291989.0 in 2023, then tumbled by 257.83% to -$460836.0 in 2024, then skyrocketed by 65.66% to -$158232.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were -$158232.0 in Q3 2025, -$167797.0 in Q2 2025, and $24698.0 in Q1 2025.